ARTAX BIOPHARMA, INC.

Profile

Company Names

ARTAX BIOPHARMA, INC.

Addresses

ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142

1 BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

617-368-0676
617-401-2168

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$55,966,215.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-07-31 
$19,000,000.00 
$19,000,000.00 
$0.00 
Debt 
7
2021-12-17 
$25,785,117.00 
$25,785,117.00 
$0.00 
Equity 
6
2021-02-16 
$2,155,015.00 
$3,000,000.00 
$844,985.00 
Debt 
5
2020-04-17 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
4
2019-07-31 
$750,000.00 
$3,500,000.00 
$2,750,000.00 
Equity 
3
2015-07-29 
$3,000,000.00 
$10,000,000.00 
$7,000,000.00 
Equity 
2
2014-07-17 
$2,007,827.00 
$2,007,827.00 
$0.00 
Equity 
1
2013-06-24 
$1,268,256.00 
$2,000,000.00 
$731,744.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ARMSTRONG 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
ARMSTRONG, PH.D. 
DIRECTOR
ROBERT 
W. 
ARMSTRONG, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
CASPER 
 
BREUM 
DIRECTOR
JAN 
 
DE VRIES, PH.D. 
DIRECTOR
ANDRE 
 
HOEKEMA 
DIRECTOR
JOSEPH 
M. 
LOBACKI 
EXECUTIVE OFFICER, DIRECTOR
MARIA 
 
NICHOL 
EXECUTIVE OFFICER
JOE 
 
SUAREZ 
EXECUTIVE OFFICER
DAMIA 
 
TORMO 
EXECUTIVE OFFICER, DIRECTOR
DAMIA 
 
TORMO, PH.D. 
DIRECTOR
DAMIA 
 
TORMO, PH.D., MBM 
EXECUTIVE OFFICER, DIRECTOR
ALAN 
 
WALTS 
DIRECTOR
ALAN 
E. 
WALTS 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2024-07-31 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2024-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-07-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-02-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-06-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#